Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Similares en SciELO
Compartir
Salud Pública de México
versión impresa ISSN 0036-3634
Resumen
CABEZAS, César et al. Reduction of HBV and HDV infection in two indigenous peoples of Peruvian Amazon after the vaccination against hepatitis B. Salud pública Méx [online]. 2020, vol.62, n.3, pp.237-245. Epub 16-Mayo-2022. ISSN 0036-3634. https://doi.org/10.21149/11128.
Objective:
To determine the outcome of the vaccination against hepatitis, we determined the prevalence of hepatitis B virus (HBV) and hepatitis D virus (HDV) infections, eight years after introduction of the vaccination.
Materials and methods:
A cross-sectional study was performed in 2 944 participants of 67 Kandozi and Chapra indigenous peoples in April 2010. Serological screening for hepatitis B surface antigen (HBsAg), antibody anti-HBc IgM and IgG, antibody anti-HBs and anti-HDV were determined by ELISA tests.
Results:
The prevalence rates of HBsAg, anti-HBc total, anti-HBs ≥10 mlUI/ml and anti-HDV were 2.3, 39.13, 50.95 and 2.11%, respectively. The prevalence rate of HBsAg in children <11 years was 0%. Among carriers of HBsAg, the prevalence rates of HDV and acute HBV infections were 2.11% (all were >14 years) and 11.94%, respectively. HBsAg and anti-HBc total were associated with individuals ≥10 years (p<0.001).
Conclusions:
These findings show the elimination of HBV carriers in children <11 years, eight years following introduction of the vaccination against HBV.
Palabras llave : Hepatitis B; immunization; indigenous population; Peru.